Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty: A meta-analysis of randomized controlled trials

BACKGROUND: Risedronate is widely used in the therapy of osteoporosis and other metabolic bone diseases. This meta-analysis was aimed to assess whether administration risedronate could increase the bone mineral density (BMD) in patients undergoing primary total hip arthroplasty (THA). METHODS: Elect...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jing, Wei, Yi, Li, Xiao Ming, Diao, Yan-Ping, Liu, Huai-Gang, Zhang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320077/
https://www.ncbi.nlm.nih.gov/pubmed/30572438
http://dx.doi.org/10.1097/MD.0000000000013346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320077/
https://www.ncbi.nlm.nih.gov/pubmed/30572438
http://dx.doi.org/10.1097/MD.0000000000013346

Ejemplares similares